Top stories

businessstandard's picture

Indian pharma should look beyond generics

From: Buisness-standard By Ajay Srinivasan Recommended by: business-standard The generics segment isn’t quite the goose it once was, or so the trend in the pharmaceuticals industry appears to suggest. Between 2004 and 2014, the
hindustantimes's picture

Modi’s generics-only drugs plan worries health experts, Indian pharma sector

From: Hindustan Times Recommended by: Hindustan times Prime Minister Narendra Modi said last month that the government was looking at such a law to improve affordability of medicines in the country of 1.2 billion people, where the
hindustantimes's picture

‘Trump’s push for lower drug prices to benefit Indian pharma’

From: Hindustan Times Recommended by: Hindustan times Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug prices since the country’s generic medicines are
businessstandard's picture

Shyamal Majumdar: Daiichi Sankyo's self-goal

From: Buisness-standard By Shyamal Majumdar Recommended by: business-standard Joji Nakayama, Daiichi Sankyo's president and chief executive officer, has surely mastered the art of keeping a straight face even while suffering a